Philipp Kaldis
61 – 70 of 150
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
TLR3 agonist and Sorafenib combinatorial therapy promotes immune activation and controls hepatocellular carcinoma progression
- Contribution to journal › Article
-
Mark
Mastl/PP2A regulate Cdk1 in ooycte maturation
- Contribution to journal › Review (Book/Film/Exhibition/etc.)
-
Mark
MEN1 tumorigenesis in the pituitary and pancreatic islet requires CDK4 but not Cdk2
- Contribution to journal › Article
-
Mark
Hematopoiesis specific loss of Cdk2 and Cdk4 results in increased erythrocyte size and delayed platelet recovery following stress
- Contribution to journal › Article
- 2014
-
Mark
Identification of transcriptional and metabolic programs related to mammalian cell size
- Contribution to journal › Article
-
Mark
Mastl is required for timely activation of APC/C in meiosis I and Cdk1 reactivation in meiosis II
- Contribution to journal › Article
-
Mark
Spy1/SpeedyA accelerates neuroblastoma
- Contribution to journal › Scientific review
-
Mark
Loss of Cdk2 and cyclin A2 impairs cell proliferation and tumorigenesis
- Contribution to journal › Article
-
Mark
P57Kip2regulates T-cell development and lymphoma
- Contribution to journal › Scientific review
-
Mark
Xenopus Cdc7 executes its essential function early in S phase and is counteracted by checkpoint-regulated protein phosphatase 1
- Contribution to journal › Article
